Harbin Pharmaceutical Group Co Ltd (600664) — Cash Flow Reinvestment Rate
Harbin Pharmaceutical Group Co Ltd (600664) has a Cash Flow Reinvestment Rate of 0.12x as of June 2025, reinvesting CN¥38.54 Million (capex CN¥20.49 Million plus investments CN¥-18.05 Million) from operating cash flow of CN¥323.33 Million. See 600664 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Harbin Pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate (1998–2024)
Historical reinvestment intensity for Harbin Pharmaceutical Group Co Ltd across 23 annual periods. For the full cash flow conversion analysis, see how efficiently does Harbin Pharmaceutical Group Co Ltd generate cash.
Annual Cash Flow Reinvestment Rate for Harbin Pharmaceutical Group Co Ltd (1998–2024)
Year-by-year capital reinvestment analysis for Harbin Pharmaceutical Group Co Ltd. See how financially flexible is Harbin Pharmaceutical Group Co Ltd to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.13x | CN¥101.52 Million | CN¥792.50 Million | CN¥100.81 Million | ▲ +39.6% |
| 2023 | 0.09x | CN¥87.12 Million | CN¥949.67 Million | CN¥86.54 Million | ▼ -64.8% |
| 2022 | 0.26x | CN¥161.98 Million | CN¥622.09 Million | CN¥89.65 Million | ▼ -77.6% |
| 2018 | 1.16x | CN¥806.46 Million | CN¥692.72 Million | CN¥114.11 Million | ▲ +31.6% |
| 2017 | 0.88x | CN¥132.01 Million | CN¥149.22 Million | CN¥102.01 Million | ▲ +1236.9% |
| 2016 | 0.07x | CN¥183.82 Million | CN¥2.78 Billion | CN¥107.46 Million | ▼ -65.8% |
| 2015 | 0.19x | CN¥320.75 Million | CN¥1.66 Billion | CN¥290.75 Million | ▼ -41.5% |
| 2014 | 0.33x | CN¥375.37 Million | CN¥1.14 Billion | CN¥375.37 Million | ▼ -87.3% |
| 2013 | 2.61x | CN¥369.90 Million | CN¥141.64 Million | CN¥369.90 Million | ▲ +428.2% |
| 2012 | 0.49x | CN¥275.78 Million | CN¥557.83 Million | CN¥275.78 Million | ▲ +90.5% |
| 2010 | 0.26x | CN¥299.19 Million | CN¥1.15 Billion | CN¥299.19 Million | ▲ +115.3% |
| 2009 | 0.12x | CN¥223.26 Million | CN¥1.85 Billion | CN¥223.26 Million | ▼ -51.2% |
| 2008 | 0.25x | CN¥143.09 Million | CN¥578.59 Million | CN¥143.09 Million | ▼ -8.1% |
| 2007 | 0.27x | CN¥175.00 Million | CN¥650.16 Million | CN¥175.00 Million | ▼ -39.1% |
| 2006 | 0.44x | CN¥326.28 Million | CN¥738.08 Million | CN¥326.28 Million | ▼ -24.5% |
| 2005 | 0.59x | CN¥443.61 Million | CN¥757.76 Million | CN¥443.61 Million | ▼ -79.6% |
| 2004 | 2.88x | CN¥428.60 Million | CN¥149.01 Million | CN¥428.60 Million | ▲ +83.9% |
| 2003 | 1.56x | CN¥473.73 Million | CN¥302.83 Million | CN¥473.73 Million | ▲ +53.4% |
| 2002 | 1.02x | CN¥391.03 Million | CN¥383.44 Million | CN¥391.03 Million | ▼ -3.0% |
| 2001 | 1.05x | CN¥635.28 Million | CN¥604.13 Million | CN¥635.28 Million | ▼ -2.2% |
| 2000 | 1.08x | CN¥582.49 Million | CN¥541.70 Million | CN¥582.49 Million | ▲ +151.4% |
| 1999 | 0.43x | CN¥184.43 Million | CN¥431.22 Million | CN¥184.43 Million | ▼ -6.0% |
| 1998 | 0.45x | CN¥100.73 Million | CN¥221.41 Million | CN¥100.73 Million | — |